These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 19147669

  • 41. Enalapril dosage in steroid-resistant nephrotic syndrome.
    Bagga A, Mudigoudar BD, Hari P, Vasudev V.
    Pediatr Nephrol; 2004 Jan; 19(1):45-50. PubMed ID: 14648339
    [Abstract] [Full Text] [Related]

  • 42. A case of nephrotic syndrome with rapid spontaneous remission in an elderly patient.
    Kanahara K, Yorioka N, Kumagai J, Amimoto D, Nishiki T, Ochiai M, Taniguchi Y, Yamakido M.
    Hiroshima J Med Sci; 1997 Sep; 46(3):93-7. PubMed ID: 9353969
    [Abstract] [Full Text] [Related]

  • 43. Effectiveness of Supramaximal Angiotensin-converting Enzyme Inhibition in Controlling Proteinuria in Congenital Nephrotic Syndrome with Cytomegalovirus Infection and an NPHS1 Mutation.
    Dange N, Sathe KP, Kondekar A, Sawant V.
    Saudi J Kidney Dis Transpl; 2023 Sep 01; 34(5):462-467. PubMed ID: 38995307
    [Abstract] [Full Text] [Related]

  • 44. Different patterns of one-year evolution of microalbuminuria in hypertensive patients treated with different inhibitors of the renin-angiotensin system.
    Cotter J, Oliveira P, Cunha P, Polónia J.
    Rev Port Cardiol; 2008 Nov 01; 27(11):1395-404. PubMed ID: 19227807
    [Abstract] [Full Text] [Related]

  • 45. Antiproteinuric action of amiloride in paediatric patient with corticoresistant nephrotic syndrome.
    Liern M, Colazo A, Vallejo G, Zotta E.
    Nefrologia (Engl Ed); 2021 Nov 01; 41(3):304-310. PubMed ID: 33722403
    [Abstract] [Full Text] [Related]

  • 46. Non-immunologic mechanisms of calcineurin inhibitors explain its antiproteinuric effects in genetic glomerulopathies.
    Bensman A, Niaudet P.
    Pediatr Nephrol; 2010 Jul 01; 25(7):1197-9. PubMed ID: 20195644
    [Abstract] [Full Text] [Related]

  • 47. Improvement of nephrotic syndrome by intensive lipid-lowering therapy in a patient with lipoprotein glomerulopathy.
    Matsunaga A, Furuyama M, Hashimoto T, Toyoda K, Ogino D, Hayasaka K.
    Clin Exp Nephrol; 2009 Dec 01; 13(6):659-62. PubMed ID: 19603250
    [Abstract] [Full Text] [Related]

  • 48. Anaemia after enalapril in a child with nephrotic syndrome.
    Sackey AH.
    Lancet; 1998 Jul 25; 352(9124):285-6. PubMed ID: 9690411
    [No Abstract] [Full Text] [Related]

  • 49. A hepatitis C-positive patient with new onset of nephrotic syndrome and systemic amyloidosis secondary to common variable immunodeficiency.
    Turkmen K, Anil M, Solak Y, Atalay H, Esen H, Tonbul HZ.
    Ann Saudi Med; 2010 Jul 25; 30(5):401-3. PubMed ID: 20697163
    [Abstract] [Full Text] [Related]

  • 50. Pierson syndrome in an adolescent girl with nephrotic range proteinuria but a normal GFR.
    Lehnhardt A, Lama A, Amann K, Matejas V, Zenker M, Kemper MJ.
    Pediatr Nephrol; 2012 May 25; 27(5):865-8. PubMed ID: 22228401
    [Abstract] [Full Text] [Related]

  • 51. Nail-patella glomerulopathy without associated constitutional abnormalities.
    Zuppan CW, Weeks DA, Cutler D.
    Ultrastruct Pathol; 2003 May 25; 27(5):357-61. PubMed ID: 14708727
    [Abstract] [Full Text] [Related]

  • 52. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
    Abe M, Okada K, Maruyama T, Matsumoto K.
    Pharmacotherapy; 2009 Sep 25; 29(9):1061-72. PubMed ID: 19698011
    [Abstract] [Full Text] [Related]

  • 53. Enalapril in paediatric patients with Alport syndrome: 2 years' experience.
    Proesmans W, Knockaert H, Trouet D.
    Eur J Pediatr; 2000 Jun 25; 159(6):430-3. PubMed ID: 10867848
    [Abstract] [Full Text] [Related]

  • 54. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
    Perkins RM, Aboudara MC, Uy AL, Olson SW, Cushner HM, Yuan CM.
    Am J Kidney Dis; 2009 Apr 25; 53(4):606-16. PubMed ID: 19216016
    [Abstract] [Full Text] [Related]

  • 55. Management of patients with nephrotic syndrome.
    de Seigneux S, Martin PY.
    Swiss Med Wkly; 2009 Jul 25; 139(29-30):416-22. PubMed ID: 19680831
    [Abstract] [Full Text] [Related]

  • 56. [Progress of pediatric nephrology].
    Kondo S, Urushihara M, Kagami S.
    Nihon Jinzo Gakkai Shi; 2011 Jul 25; 53(1):10-4. PubMed ID: 21370571
    [No Abstract] [Full Text] [Related]

  • 57. [Transient renal failure in a newborn due angiotensin receptor II antagonist use during pregnancy: report of a case].
    Hasbún H J, Valdés R E, San Martín O A, Catalán M J, Salinas Q S, Parra C M.
    Rev Med Chil; 2008 May 25; 136(5):624-30. PubMed ID: 18769811
    [Abstract] [Full Text] [Related]

  • 58. Nail-patella syndrome with an emphasis on the risk of renal and ocular findings.
    Kamath S, Bhagwandas K.
    Pediatr Dermatol; 2010 May 25; 27(1):95-7. PubMed ID: 20199424
    [Abstract] [Full Text] [Related]

  • 59. Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3-5 chronic kidney disease.
    Abe M, Okada K, Maruyama T, Maruyama N, Matsumoto K.
    Hypertens Res; 2009 Apr 25; 32(4):270-5. PubMed ID: 19262495
    [Abstract] [Full Text] [Related]

  • 60. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
    Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.